Cost-effectiveness of FDG-PET for the management of the surgically treatable non-small cell lung cancer (NSCLC): Priority for a PET-based strategy after nodale negative CT results - Dietlein, M; Weber, K; Gandjour, A (Eur J Nucl Med, 2000)